Effect of a Behavioral Weight Loss Intervention in People With Serious Mental Illness and Diabetes
Open Access
- 14 February 2019
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 42 (5) , 804-809
Abstract
OBJECTIVE: Given the high prevalence of obesity and diabetes in patients with serious mental illness (SMI) and the lack of evidence on the effects of weight loss programs in SMI patients with diabetes, we evaluated the effectiveness of a behavioral weight loss intervention among SMI participants with and without diabetes.RESEARCH DESIGN AND METHODS: Using data from ACHIEVE, a randomized controlled trial to evaluate the effects of a behavioral weight loss intervention among overweight/obese people with SMI, we assessed and compared weight change from baseline to 18 months in participants with and without diabetes using a longitudinal mixed-effects model.RESULTS: Of the 291 trial participants, 82 (28.2%) participants had diabetes (34 and 48 in intervention and control groups, respectively) at baseline. Participants with diabetes were more likely to be taking antipsychotics (31.7% vs. 18.7%, P = 0.02). At 18 months, participants in the control group with diabetes lost 1.2 lb (0.6%) of body weight compared with 0.8 lb (0.7%) among those without diabetes. In the intervention group, participants with diabetes lost 13.7 lb (6.6%) of their initial body weight compared with 5.4 lb (2.9%) for those without diabetes. Corresponding net effects (intervention minus control) were 4.6 lb (2.2%) and 12.5 lb (6.0%) net weight reduction over 18 months in the no diabetes and the diabetes subgroups, respectively. However, the between-group difference in intervention effects was statistically nonsignificant (absolute weight change: P-interaction = 0.08; % weight change: P-interaction = 0.10).CONCLUSIONS: A behavioral weight loss intervention is effective among overweight and obese individuals with SMI regardless of their diabetes status.Keywords
Funding Information
- National Institute of Mental Health (R01MH080964, K24MH09373, P50MH115842, R01MH080964, P50MH115842)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079637)
This publication has 25 references indexed in Scilit:
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsWorld Psychiatry, 2013
- Weight loss for individuals with type 2 diabetes following a very‐low‐calorie diet in a community‐based setting with trained facilitators for 12 weeksClinical Obesity, 2013
- Association of Psychiatric Illness and Obesity, Physical Inactivity, and Smoking among a National Sample of VeteransPsychosomatics, 2011
- Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: A systematic reviewInternational Journal of Behavioral Nutrition and Physical Activity, 2011
- Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trialBMC Psychiatry, 2010
- Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophreniaDiabetic Medicine, 2007
- Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIISchizophrenia Research, 2005
- Consensus Statement: Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesThe Journal of Clinical Psychiatry, 2004
- Comparison of Obese NIDDM and Nondiabetic Women: Short‐ and Long‐Term Weight LossObesity Research, 1995
- Type II Diabetic Subjects Lose Less Weight Than Their Overweight Nondiabetic SpousesDiabetes Care, 1987